Sonnet BioTherapeutics
SONN
SONN
18 hedge funds and large institutions have $997K invested in Sonnet BioTherapeutics in 2022 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 4
Holders
18
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$57.3K | |
| 2 | +$22.3K | |
| 3 | +$17.7K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$17.2K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.5K |
Top Sellers
| 1 | -$481K | |
| 2 | -$106K | |
| 3 | -$97.6K | |
| 4 |
VF
Virtu Financial
New York
|
-$42K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$34.4K |